Nippon Kayaku Co., Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2018/07/30 | ¥18.50 | ¥25.65 | +38.7% |
| 2017/05/09 | ¥- | ¥27.62 | - |
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
2.1M | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.3M | +1.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.
|
994.0K | 0.00% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
992.1K | 0.00% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
691.5K | 0.00% | |
|
Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund
|
641.6K | -0.96% |
Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥36 | -46.7% |
| 2025 | ¥68 | +50.0% |
| 2024 | ¥45 | -5.3% |
| 2023 | ¥48 | +5.6% |
| 2022 | ¥45 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥184,805M | ¥198,380M | ¥201,791M | ¥222,584M |
| Gross Profit | ¥63,967M | ¥66,752M | ¥61,301M | ¥71,482M |
| Operating Income | ¥21,052M | ¥21,506M | ¥7,338M | ¥20,402M |
| Pretax Income | ¥23,782M | ¥21,075M | ¥7,332M | ¥22,231M |
| Net Income | ¥17,181M | ¥14,984M | ¥4,113M | ¥17,508M |
| EPS | ¥101.65 | ¥89.33 | ¥24.79 | ¥107.16 |
| Operating Margin | 11.39% | 10.84% | 3.64% | 9.17% |
| Balance Sheet | ||||
| Total Assets | ¥315,459M | ¥322,858M | ¥363,173M | ¥373,708M |
| Total Equity | ¥245,479M | ¥254,016M | ¥269,560M | ¥267,526M |
| Total Liabilities | ¥69,980M | ¥68,842M | ¥93,613M | ¥106,182M |
| Cash | ¥38,459M | ¥48,051M | ¥56,749M | ¥55,425M |
| Interest-bearing Debt | ¥16,650M | ¥19,580M | ¥31,450M | ¥42,096M |
| Equity Ratio | 77.82% | 78.68% | 74.22% | 71.59% |
| D/E Ratio | 0.07 | 0.08 | 0.12 | 0.16 |
| Cash Flow | ||||
| Operating CF | ¥23,141M | ¥20,039M | ¥23,242M | ¥25,530M |
| Investing CF | -¥10,641M | -¥15,158M | -¥19,409M | -¥27,313M |
| Financing CF | -¥11,090M | -¥7,950M | ¥3,823M | -¥4,756M |
| Free CF | ¥13,674M | ¥7,052M | ¥7,220M | -¥5,478M |
| Efficiency | ||||
| ROE | 7.00% | 5.90% | 1.53% | 6.54% |
| ROA | 5.45% | 4.64% | 1.13% | 4.68% |
Latest IR Information
-
Notification regarding the status of treasury stock acquisition
Based on the board of directors' resolution on May 12, the company will conduct market purchases of treasury stock. As of July 31, the total number of shares acquired is 3,389,700 shares, with a total acquisition amount of 6,849,550,350 yen...
Read more -
Nihon Kayaku Co., Ltd. 2027 Fiscal Year Q1 Consolidated Financial Results (Interim)
Reports key metrics such as net sales, operating income, and net income, and segment-by-segment performance. Discloses quarterly consolidated trends in sales and profits, the breakdown of financial position, and cash flow status, with considerations of future outlook and segment-specific impacts.
Read more -
IR Information: Notice Regarding Revision of Earnings Guidance
Revision of consolidated earnings forecasts for the second quarter cumulative period and the full year for the fiscal year ending March 2027. Net sales are expected at 133,800 million yen for the second quarter cumulative period, up 10,300 million yen...
Read more -
Completion of Share Buyback of Share-Restricted Stock Compensation | July 2026
Nihon Kakaku Pharmaceutical completed the disposal of 43,463 shares of treasury stock issued as share-restricted stock compensation, raising a total of 89.38 million yen.
Read more -
Notice on the Status of Share Buyback
Based on a board resolution dated May 12, 2026, we conducted a share buyback of common stock. From June 1 to June 30, 2026, the cumulative number of shares acquired through market purchases was 1,244,100 shares, with a total acquisition...
Read more
Latest News (5 items)
Company Information
About
Nippon Kayaku Co., Ltd. engages in mobility and imaging, fine chemicals, and life sciences businesses in Japan, China, Asia, the United States, and internationally. The company offers airbag inflators, micro gas generators for seatbelt pretensioners and squib; and liquid crystal display (LCD) projector and display, and x-ray analysis system components. It also provides epoxy and maleimide resin, epoxy resin hardener, reactive flame retardant, acrylic acid esters, UV-curable resins for resist, resist for MEMS, cleaners for LCDs and semiconductors, and LCD sealants, as well as semiconductor manufacturing equipment, such as laminator, remover, mounter, UV irradiation equipment; colorants for inkjet printers, dyes for inkjet textile printing, inks for industrial inkjet printers, image sensor materials, dichotomous colorants for dimmable glass, near infrared absorbers, dyes for textiles and paper, colorants for resins, developers for thermal paper, and pigment derivative; and catalysts for the production of acrylic acid, acrolein, and methacrylic acid. In addition, the company offers Anti-cancer and biological drugs, cardiovascular and photodynamic diagnostic agents, in-vitro diagnostic drugs, embolization materials, pharmaceutical API and intermediates, food additives, health food ingredients, preservatives for food quality, and cleaners and disinfectants; Insecticides, herbicides, fungicides, miticides, public health insecticides, soil fumigants, and animal repellents; and engages in real estate business. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.
